Dupilumab for Atopic Dermatitis Linked to Increased Risk of Psoriasis

By News Health
2 months Ago

(MedPage Today) — The use of dupilumab (Dupixent) for the treatment of atopic dermatitis was associated with an increased risk of psoriasis compared with other systemic agents, according to a retrospective cohort study.
Among over 19,000 matched…

Source link : https://www.medpagetoday.com/dermatology/psoriasis/116153

Author :

Publish date : 2025-06-18 20:22:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Do Patients Care About Doctors' White Coats?

Ultraprocessed vs Minimally Processed Food; Alteplase After Stroke

So You Want to Be a Medfluencer

Trump Tax Law Could Cause Medicare Cuts if Congress Doesn't Act, CBO Says

First Therapy Approved for HPV-Related Respiratory Disease

Removing Duplicate Enrollees From Medicaid, ACA Plans Is Not as Easy as You'd Think